We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NBR:NYSENabors Industries Ltd. Analysis

Data as of 2026-08-30 - not real-time

$91.71

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Nabors Industries Ltd. is bullish at $91.71, with short-term averages leading the long-term ones. The last 30 days have gained 9.3%. With RSI at 56.0 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at $78.57 and resistance at $98.01.
Multiples put this in undervalued territory: 6.2 times earnings against the sector's 21.1. Sell-side targets cluster 16.3% above the current quote. Revenue is contracting at 2.2% on a 7.7% profit margin.
The composite risk read is 7/10, putting it in elevated territory. With 30-day volatility of 55.8%, a beta of 0.73 and a maximum drawdown of 31.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons line up on buy — conviction 6 out of 10.

Top Market Events

Nabors Industries Ltd. NYSE: NBR invites you to join Anthony G. Petrello, Chairman, President and Chief Executive...Drilling services company Nabors Industries NYSE:NBR will be reporting earnings this Tuesday after market close.The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 77.86
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 6.2 versus sector average of 21.1
  • Trading above the 200-day average of 77.86

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 6.2 versus sector average of 21.1
  • Analyst targets imply +16.3% versus the current price
  • Revenue contracting at -2.2%

Key Metrics & Analysis

Financial Health

Revenue Growth-2.20%
Profit Margin7.69%
P/E Ratio6.2
ROE22.31%
ROA3.28%
Debt/Equity147.62
P/B Ratio2.5
Op. Cash Flow$702.3M
Free Cash Flow$134.2M
Industry P/E21.1

Technical Analysis

TrendBullish
RSI56.0
Support$78.57
Resistance$98.01
MA 20$88.90
MA 50$84.90
MA 200$77.86
MACDBearish
VolumeDecreasing
Fear & Greed Index95.66

Valuation

Fair Value$6.79
Target Price$106.63
Upside/Downside16.26%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.73
Volatility55.85%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.